Gene Query: BAZ2B

Dataset Description Geneva Score
TRIM28-Regulated Transposon Repression Is Required for Human Germline Competency and Not Primed or Naive Human Pluripotency 39.21
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 37.38
LSD1 pharmacological inhibition in SET-2 containing wild type and mutant LSD1 [RNA-Seq] 37.38
The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion 37.13
microRNA suppresses prostate cancer stem cells and metastasis by inhibiting a cohort of pro-metastasis targets including CD44, Rho GTPases and EZH2 30.12
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes 29.41
Cleavage Factor Im as a key regulator of 3’ UTR length 28.76
Gene expressions of H9s in different culture systems 28.45
Gene expression data from IMR90 control, IMR90 shRRM2 and shRRM2/shp16 27.0
Transcriptomic Profiling of Developing Human Paraxial Mesoderm from 4.5-5 Weeks of Gestation Human Embryos 26.55
Distinct regulatory programs for Sox9 in transcriptional regulation of the developing mammalian chondrocyte 25.86
Distinct regulatory programs for Sox9 in transcriptional regulation of the developing mammalian chondrocyte [RNA-seq] 25.86
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 25.34
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 23.77
TNF response in promyelocytic and granulocytic forms of HL60/S4 cells 22.13
Pharmacologic inhibition of STAT5 in AML 22.12
Bach1 Regulates the Self-renewal and Mesendodermal Differentiation of Human Embryonic Stem Cells 21.82
SETDB2 links E2A-PBX1 to cell cycle dysregulation in acute leukemia through CDKN2C repression [sequencing] 21.04
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells 20.7
Sequential regulatory loops as key gatekeepers for neuronal reprogramming in human cells [RNA-seq] 20.7
Selective suppression of endothelial cytokine production by progesterone receptor [RNA-seq] 19.76
Selective suppression of endothelial cytokine production by progesterone receptor 19.76
Exploring the role of macroH2A1 in transcription regulation in IMR90 primary human lung fibroblasts with RNA-seq and ChIP-seq 19.72
RNA-seq from control and macroH2A1-depleted IMR90 primary human lung fibroblasts 19.72
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] 19.69
Human HAP1 cells before and after nutrient deprivation 19.52
Transcriptomic profiling of human HAP1 cells before and after nutrient deprivation 19.52
Quantitative analysis of bi-modal binding of BET proteins at promoters predicts I-BET sensitivity 19.34
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-Seq of LMNA KD) 19.09
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements 18.75
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements [RNA-seq] 18.75
Unique features and clinical importance of acute alloreactive immune responses 18.33
COMBINING BET AND MEK INHIBITORS SYNERGISTICALLY TARGETS NRAS MUTANT MELANOMA 18.03
The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia 17.92
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 17.46
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [HCC1599_RNA-seq] 17.46
In Vivo Chemical Screen Nominates Valproic Acid as Pharmacologic Modulator of Hematopoietic Stem and Progenitor Cell Activity 17.17
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 17.05
Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed 17.04
Isogenic patient-derived human iPSCs, wild-type or heterozygous for PIK3CA-E418K 16.62
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 16.62
Differentiation enhances Zika virus infection in neuronal brain cells 16.56
Real-time observation of light-controlled transcription in living cells 16.52
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq B-ALL) 15.97
RNA-Seq and ATAC-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 15.85
RNA-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 15.85
A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo 15.59
A Brain Penetrant Mutant IDH1 Inhibitor Provides In Vivo Survival Benefit 15.58
DJ-1 is dispensable for human stem cell homeostasis 15.53
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 15.51
Treatment of multiple myeloma cells with EZH2 small molecule inhibitor 15.41
Temporal activation of NR5A2 and RARγ induce functional human naïve pluripotent state via modulating TGFβ pathway 15.19
RNA-seq in untreated and flagellin-treated Human Intestinal Myofibroblast cells (HIMF) 15.18
The role of TFEB in retinoid induced differentiation of NB4 APL leukemic cells (shTFEB) 15.11
Effect of TUNAR silencing and GSK3 inhibition on human b-cell transcriptome 14.54
Glutaminolysis is a metabolic dependency in FLT3 ITD Acute Myeloid Leukemia unmasked by FLT3 Tyrosine Kinase Inhibition 14.45
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer 14.44
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer [RNA-Seq] 14.44
RNASeq of MV4;11 cells transduced with scramble shRNA or BRD4 shRNA in combination with DMSO or SGC0946 14.43
Gene expression changes caused by KRAS in MCF-10A 14.25
Post-transcriptional remodelling is temporally deregulated during motor neurogenesis in human ALS models 13.76
Molecular mechanism underlying increased ischemic damage in the ALDH2*2 genetic polymorphism using a human iPSC model system 13.62
Gene expression profiles of primary human NK cells before and after expansion on CSTX002 feeder cells, with and without IL-21 stimulation 13.47
mRNA sequencing of clinical-grade neural stem cells derived from human ES cells 13.39
List of TIAM1 differentially expressed genes in SW620 cells [RNA-seq] 13.17
The inhibitory effect of TIAM1 on TAZ transcriptional activity and TIAM1 differentially expressed genes 13.17
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 13.1
Transcript abundance in A-T-derived iPSC: Comparing isogenic cells to unrelated individual 13.09
Radiomic and gEnomic approaches for the enhanced DIagnosis of REnal Cancer (REDIRECt): A translational pilot study 13.06
Pericyte-like cells generated from human pluripotent stem cells support hematopoietic stem and progenitors ex vivo 13.04
NRDE2 negatively regulates nuclear exosome functions 13.02
RNASeq of 4SU labelled nascent RNA in MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 13.0
The landscape of alternative splicing in aggressive prostate cancers 12.81
Dysregulated immune system networks in war veterans with PTSD 12.7
RNA-seq in acute myeloid leukemia (AML) cells with and without knockdown of METTL14 12.56
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 12.51
Lineage specific differentiation is influenced by state of human pluripotency [RNA-seq] 12.49
Lineage specific differentiation is influenced by state of human pluripotency 12.49
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 12.45
MeRIP sequencing reveals angiogenic properties of vascular endothelial cells 12.1
Induction of human SST and PV neurons by expressing a single transcription factor LHX6 12.03
RNA-sequencing (RNA-seq) in BxPC-3 and S2-007 cell lines 12.03
A novel lncRNA lncRNA-AK096729 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 11.91
Effect of Ro 08-2750 treatment on gene expression of human leukemia cell lines MOLM13 and K562 11.9
Parkinson’s Disease Genetic Risk in a Midbrain Neuronal Cell Line 11.87
Recapitulation of Human Neural Microenvironment Signatures in iPSC-Derived NPC 3D Differentiation 11.86
Transcription elongation regulates genome 3D structure 11.74
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 11.63
Reassessment of Exosome Composition 11.61
Retinoic acid suppresses MYB in adenoid cystic carcinoma 11.6
Retinoic acid suppresses MYB in adenoid cystic carcinoma [RNA-seq] 11.6
Global Mapping of Human RNA-RNA Interactions 11.6
H3K27Ac in MCF7 Y537S ER mutant cells and RNAseq with and without treatment with THZ1 11.6
Toxoplasma gondii infection of human retinal pigment epithelial cells 11.57
Progressive motor neuron pathology and the role of astrocytes in a human stem cell model of VCP-related ALS 11.52
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 11.47
Patient iPSC-derived neural stem cells display progressive enlargement of lysosomes and disruptions of glycosaminoglycan pathway and autophagy in concordance with clinical severity of Mucopolysaccharidosis I 11.41
Verification and rectification of cell type-specific splicing of a Seckel syndrome-associated ATR mutation using iPS cell model 11.36
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 11.32
Indoxyl sulfate stimulates angiogenesis by regulating reactive oxygen species production via CYP1B1 11.27
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 11.21
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 11.1
Transcriptome analysis of BAP1 knockout and restoration 10.77
Expression profiles of restoration of BAP1 in a BAP1 deficient cell line 10.77
Functional interactions between Mi-2β and AP1 complexes control response and recovery from barrier disruption 10.76
Transcriptomic analysis of human tonsillar TFH subsets 10.71
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected EVT cells 10.67
Estrogen deprivation triggers and immunosuppressive phenotype in breast cancer cells 10.67
Intron retention induced by microsatellite expansions as a disease biomarker. 10.62
Studying iPSCs from a hibernating mammal reveals molecular mechanisms of cold resistance in neural tissues 10.56
Genome-wide profiling of siRNA targeting EWS-FLI1 in TC32 Ewing sarcoma cell line 10.52
Effects on gene expression of ibrutinib treatment in human stem cells-derived atrial- and ventricular-like cardiomyocytes 10.41
Human iPSC derived glomeruli facilitate accurate modelling of podocytopathy 10.4
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma 10.4
Novel Form of JARID2 is Required to Regulate Differentiation in Keratinocytes. 10.33
The cohesin complex prevents Myc-induced replication stress 10.25
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 10.19
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 10.19
Cooperation between TLX1 and the NUP214-ABL1/STAT5 signaling in T-cell acute lymphoblastic leukemia 10.18
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains 10.14
SnapShot-Seq: a method for extracting genome-wide, in vivo mRNA dynamics from a single total RNA sample 10.13
Transcriptome of human keratinocytes with or without HPV16 oncogene expression 10.12
Endothelial gene expression analysis 10.08
Total RNA deep sequencing (ribosomal depleted) of human umbilical vein endothelial cells exposed to hypoxia (0.2%) for 12h and 24h or kept under normoxic conditions. 10.08
Gene expression in mature and immature human ES-derived beta cells, and sorted beta-cells from adult islets 10.05
Whole transcriptome sequencing identifies increased CXCR2 expression in PNH granulocytes 10.04
Role of miR-146a in neural stem cell differentiation and neural lineage determination: relevance for neurodevelopmental disorders 10.01
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 10.0
Microprocessor mediates transcription termination in long noncoding microRNA genes 10.0
Dynamic 3D chromosomal landscapes in acute leukemia [RNA-Seq] 9.96
Dynamic 3D chromosomal landscapes in acute leukemia 9.96
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 9.95
Genetic and pharmacological restoration of TET2 function blocks stem cell self-renewal and progression of leukemia 9.81
RNA-sequencing of human leukemia cells and mouse hematopoietic progenitors 9.81
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [ChrRNA-seq] 9.78
RNA-Seq analysis of cSCC cells after siRNA-induced gene knockdown of lncRNA PRECSIT 9.75
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 9.7
mRNA-Seq profiling of human developing kidney 9.68
An RNA-centric dissection of host complexes controlling flavivirus infection 9.65
An RNA-centric dissection of host complexes controlling flavivirus infection [RNA-Seq] 9.65
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress 9.64
AMPK signaling for naïve pluripotency [Hs] 9.54
AMPK signaling for naïve pluripotency 9.54
Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13 9.54
Capturing the Interactome of Newly Transcribed RNA (RICK) 9.5
Capturing the Interactome of Newly Transcribed RNA 9.5
Targeting EZH2 in MYCN-amplified Neuroblastoma 9.45
Targeting EZH2 in MYCN-amplified Neuroblastoma [RNA-seq] 9.45
Adaptive chromatin remodeling in glioblastoma stem cell plasticity and drug tolerance 9.45
TGF-β promotes genomic instability after loss of RUNX3 9.39
Human Sandhoff Disease Cerebral Organoids Exhibit Enlarged Size, Increased Cellular Proliferation, and Impaired Differentiation 9.35
Subcellular RNA fractions of HSV-1 infected primary human fibroblasts 9.35
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 9.22
Post-transcriptional manipulation of TERC reverses molecular hallmarks of telomere disease 9.18
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 9.15
Neural cell adhesion molecule 1 (NCAM1; CD56) promotes leukemogenesis and confers drug resistance in acute myeloid leukemia. 9.13
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 9.11
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 9.03
Similarity of therapeutic networks induced by a multi-component herbal remedy in neurovascular unit cells 8.93
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq SS] 8.93
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 2) 8.93
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase 8.84
PTEN suppresses neoplastic transformation of human neural stem cells by transcriptional repression of Pax7 8.77
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation (Human_RWPE1_RNA-Seq) 8.77
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation 8.77
Single-cell RNA-Seq Investigation of Foveal and Peripheral Expression in the Human Retina 8.76
Effect of BCL11B overexpression on transcriptome of T-cell acute lymphoblastic leukemia (T-ALL) cells 8.75
Transcriptome profiling of microRNA-mediated neuronal reprogramming with REST repression at day 7 8.71
RNA-seq of H1299 cells in which either PRKCI or SOX2 was silenced by validated lentiviral shRNA constructs 8.7
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 8.61
Transcriptomic Profiling of Posterior Polymorphous Corneal Dystrophy 8.59
Transcriptome analysis revealed impaired cAMP responsiveness in PHF21A-deficient human cells 8.58
JQ1 +/- Vemurafenib in BRAF mutant melanoma (A375) 8.56
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 8.56
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 8.53
LncRNA-GAS5 negative regulation of YAP-target genes expression 8.52
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 8.52
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation 8.5
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation [RNA-seq] 8.5
Identification of the networks that regulate human monocytic myeloid-derived suppressor cell differentiation into inflammatory macrophages 8.49
Paxillin regulates genomic networks in prostate cancer [LNCaP] 8.48
RNA sequencing for lncRNA, miRNA and mRNA expression analysis in human laryngeal cancer 8.44
Comparative gene expression profiling of human primary endotheliocytes cultivated on polyurethane-based electrospun 3D matrices and natural decellularized vein 8.44
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 8.42
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 8.34
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 8.34
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 8.32
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 8.27
The evolution of N6-methyladenosine in primates 8.26
RNA-sequencing of fibrolamellar carcinoma (FLC) cell line treated with miR-375 mimic 8.25
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages (RNA-Seq, CAGE and ChIP-Seq) 8.2
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages 8.2
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 8.2
Region-specific Innate Antiviral Responses of the Human Epididymis 8.16
miRNAs affected by antagomiR-17 treatment 8.13
Differential expression of human parthenogenic stem cells, neural stem cells and DA progenitors. 8.13
Simultaneous and systematic analysis of cellular and viral gene expression during Enterovirus 71-induced host shutoff 8.13
The mSWI/SNF ATPase module mediates subcomplex identity and non-catalytic targeting in SCCOHT [RNA-seq] 8.08
The ATPase module of mammalian SWI/SNF family complexes mediates subcomplex identity and catalytic activity-independent genomic targeting 8.08
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 8.07
RNA-seq analysis of FET cells treated with RSPO1 or TGFβ1 8.04
Primary human trophoblast from term placenta 8.02
CD1c+ dendritic cell activation by Plasmodium falciparum-infected red blood cells 7.99
Allelic expression mapping across cell lineages reveal repressor disruption among disease SNPs 7.97
Differentially expressed genes post knock down of lincDUSP26 7.93
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies 7.81
Click chemistry enables comprehensive preclinical evaluation of targeted epigenetic therapies [RNA-seq] 7.81
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 7.77
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens 7.77
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens [RNA-Seq] 7.77
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction (RNA-Seq) 7.72
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction 7.72
RNA seq comparison between scrambled and shGRP78 cells 7.67
Pitfalls in Single Clone CRISPR-Cas9 Mutagenesis to Fine-map Regulatory Intervals 7.62
Epigenetic siRNA and chemical screens identify SETD8 inhibition as a new therapeutic strategy of p53 reactivation in high-risk Neuroblastoma. 7.58
Human co-transcriptional splicing kinetics and coordination revealed by direct nascent RNA sequencing 7.55
Zone dependent distinctive gene expression profile of the normal human liver tissue 7.52
Whole-transcriptome profilings between a pair of HCA7-derived KRAS-wildtype cetuximab sensitive and resistant colon cancer cells from 3D culture 7.51
Genomic basis for clinical response to histone deacetylase inhibition in advanced urothelial carcinoma 7.48
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain [RNA-Seq] 7.44
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain 7.44
Synectin Promotes Fibrogenesis by Regulating PDGFR Isoforms Through Distinct Mechanisms 7.43
Transcriptome of diurnal human blood neutrophils 7.41
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 7.36
Global transcriptome analysis of HAP1 cells 7.32
Human cell line and subcutaneous tumor 7.3
Uridilation by TUT4/7 restricts retrotransposition of human Line-1s 7.29
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 7.28
RNA-seq analysis of Retinoic Acid and Non-treated Control hiPSCs 7.27
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 7.27
Transcriptome analysis reveals determinant stages controlling human embryonic stem cell commitment to neuronal cells 7.26
Genome-wide Gene Expression Profiling in DLBCL Cell Lines Treated with CUDC-907 7.25
Circular RNA expression signature of low-glucose-treated MIA PaCa-2 cells 7.2
RNA-seq analysis of gene expression patterns during hESC neural differentiation 7.2
hESC neural differentiation 7.2
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells 7.17
mRNA gene expression profiling in a human AML cell line treated with small molecule inhibitors that impact different RNA polymerase transcription complexes, or their combination, in comparison to a global DNA-damaging anthracycline compound 7.17
The ribonuclease activity of SAMHD1 is required for HIV-1 restriction 7.13
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype 7.12
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype [RNA-seq] 7.12
RNA sequencing of mechanically strained NHEKs and control NHEKs 7.03
SOX17 Is a Critical Specifier of Human Primordial Germ Cell Fate 6.99
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 6.98
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 6.98
RNA-Sequencing of human dermal lymphatic endothelial cells (HDLEC) treated with siRNA targeting YAP/TAZ and YAP5SA 6.98
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer 6.98
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer [RNA-seq] 6.98
Expression profiles of long non-coding RNAs located in autoimmune disease-associated regions reveal immune cell type specificity 6.91
E2F1 orchestrates transcriptomics and oxidative metabolism in Wharton’s jelly derived mesenchymal stem cells from growth-restricted neonates 6.91
Gene expression analysis of human hepatocellular cancers 6.87
High capacity of the endoplasmic reticulum to prevent secretion and aggregation of amyloidgenic proteins 6.85
Hypoxic transcriptome of SQ20B human head and neck cancer cells 6.85
Hemogenic Endothelium transcriptome along the timeline of hESC differentiation 6.85
HLA peptides derived from tumor antigens induced by inhibition of DNA methylation for development of drug-facilitated immunotherapy 6.84
Integrating the Epigenome to Identify Novel Drivers of Hepatocellular Carcinoma 6.81
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I 6.8
RNA-sequencing of human mammary epithelial cells (HMLEs) engineered to express either ER or ER-SOX4 with and without 4-OHT to induce nuclear translocation 6.75
Immunophenotyping and Transcriptomic Outcomes in PDX-Derived TNBC Tissue 6.72
Transcriptome variation among human embryonic stem cell lines impacts on their differentiation 6.69
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 6.66
IMP3 regulated gene expression in breast cancer cells 6.6
An epigenetic mark of polycomb response elements implemented by Trx/MLL/COMPASS 6.6
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification 6.58
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 6.58
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition (RNA-seq) 6.54
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition 6.54
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 6.48
RNA-seq profiling identifies Androgen Receptor-regulated genes in prostate cancer cells 6.47
Androgen Receptor-regulated genes in prostate cancer cells 6.47
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA_seq_Whole] 6.45
RNA-seq analysis of the role of HBO1 (KAT7/MYST2) in the ovarian cancer cell line UWB1.289. 6.45
Simultaneous profiling of sexually transmitted bacterial pathogens, microbiome, and concordant host response in cervical samples using whole transcriptome sequencing analysis 6.44
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 6.42
Transcriptomes of human monocytes after ex vivo exposure to uric acid 6.35
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq] 6.31
Comparative Analysis of the Transcriptome of Latent Autoimmune Diabetes (LADA) Patients from Eastern China 6.3
Transcriptional landscape of epithelial and immune cell populations revealed through FACS-seq of healthy human skin 6.28
Targeting MTHFD2 in Acute Myeloid Leukemia 6.19
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 6.11
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing (Total RNA sequencing) 6.09
Recovery and analysis of nascent RNA 6.09
The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains 6.09
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 6.07
TGF-β regulation of miRNA expression in pancreatic cancer 6.04
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II 5.98
lncRNA expression analysis in patients with eosinophilic and neutrophilic asthma 5.98
Reversing Abnormal Neural Development by Inhibiting OLIG2 in Down Syndrome Human iPSC Brain Organoids and Neuronal Mouse Chimeras 5.97
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [RNA-seq] 5.97
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 5.94
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 5.89
SOX10 Single Transcription Factor Based Fast and Efficient Generation of Oligodendrocytes from Human Pluripotent Stem Cells 5.87
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 5.83
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 5.8
RUNX1 contributes to higher-order chromatin organization and gene regulation in breast cancer cells. 5.76
IRF2 is a master regulator of human keratinocyte stem cell fate [RNA-seq] 5.76
IRF2 is a master regulator of human keratinocyte stem cell fate 5.76
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 5.74
SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-dependent Tumors 5.73
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 5.72
SETBP1-WT and SETBP1-G870S epigenetic landscapes 5.72
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation (RNA-Seq) 5.7
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation 5.7
RNA-Seq of human PDA cell lines transfected with control siRNA or Pdx1 siRNA 5.69
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 5.68
RNA-seq of cultured human kidney peritubular microvascular endothelial cells following exposure to cyclosporine A 5.61
Global gene expression profiles of cardiac progenitors differentiated from human pluripotent stem cells in 3D culture under simulated microgravity 5.61
The human blood-nerve barrier transcriptome 5.57
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 5.55
Rapid neurogenesis through transcriptional activation in human stem cell (RNA-Seq) 5.51
Cyclophosphamide (CTX) Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression 5.48
Transcriptome analysis of peripheral blood monocytes 5.48
A map of gene expression in neutrophil-like cell lines 5.48
ChIPseq and RNAseq analysis of T47D cells with/without silencing TRPS1/CHD4 5.45
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 5.42
Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events 5.34
Epigenetic Therapy Increases Therapeutic Efficacy in Myeloproliferative Neoplasms Through Inhibition of Aberrant Inflammatory Signaling 5.33
mRNA expression profile of Lymphocytes 5.16
Apolipoprotein E4 Expression Causes Gain of Toxic Function in Isogenic Human Induced Pluripotent Stem Cell-Derived Endothelial Cells 5.08
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia [RNA-seq] 5.03
mRNA sequencing identifies differential gene expresssion profiles between ASCC3 knock-down cells and control cells 5.01
STX4 Over-Expression in Human islets 4.89
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs [GRO-seq II] 4.88
Transcriptomes of human monocytes and monocyte-derived macrophages with or without glucocorticoid treatment 4.85
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 4.74
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with ENST00000431060 shRNA or control shRNA 4.68
Transcriptomic Dynamics during Differentiation Process of Human Pluripotent Cells into Hepatocyte-like Cells 4.65
Neutrophils in systemic onset Juvenile Idiopathic Arthritis display sepsis-like features which can be reverted by IL-1 blockade 4.61
Gene expression profiles of tumor-infiltrating CD8 T cells in hepatocellular carcinoma 4.51
scRNASeq analysis of cycling cardiomyocytes 4.47
Direct Isolation and Characterization of Human Nephron Progenitors. 4.37
RNA-Seq profiling in PBMCs and spinal cord from ALS patients and healthy controls 4.36
Comprehensive RNA-Seq profiling in PBMCs of ALS patients and healthy controls 4.36
Transcriptome analysis of small molecule-mediated astrocyte-to-neuron reprogramming 4.33
Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance [RNA-seq] 4.27
Pain-driven transcriptome changes in synovium of knee osteoarthritis patients 4.23
The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC derived cardiomyocytes. 4.16
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 4.12
A stably self-renewing adult blood-derived induced neural stem cell exhibiting patternability and epigenetic rejuvenation 4.05
Expression profile of MM.1S tumors folloiwing treatment with bortezomib 4.05
Mitochondrial phosphoenolpyruvate carboxykinase (PCK2) regulates metabolic adaptation and glucose-independent tumor cell growth 4.04
Gene expression profiles of 4-1BB+PD-1-high, 4-1BB-PD-1-high, and PD-1-int tumor-infiltrating CD8 T cells in hepatocellular carcinoma 4.0
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 3.99
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 3.99
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 3.95
Identification of renal resident macrophages across species 3.87
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 3.86
Transcriptome-wide response to synthetic chromatin protein PcTF 3.75
Effects on gene expression of doxorubicin in human stem cells-derived cardiomyocytes 3.71
Transcriptome analysis of Riociguat and Vehicle control treatment in human hematopoietic stem and progenitor cells 3.7
Identification of downstream genes regulated by YAP1 through knockdown and overexpression of YAP1 in U251 cell with a stably expression of mutant APP 3.69
Exploring transcriptomic landscapes in red cell populations, in their extracellular vesicles and on single cell level 3.64
Specific inhibition of DPY30 activity by peptides suppresses blood cancer cell growth 3.64
Role of cervicovaginal microbiota in genital inflammation 3.5
A faithful in vivo model of human MLL-AF4 proB acute lymphoblastic leukemia 3.5
p53 activity results in DNA replication fork processivity 3.48
BASP1 modifies the Tamoxifen response 3.38
Patterned human microvascular grafts enable rapid vascularization and increase perfusion in infarcted hearts 3.36
The lipodystrophic hotspot lamin A p.R482W mutation deregulates the mesodermal inducer T/Brachyury and early vascular differentiation gene networks 3.33
Mutated H3 Histones Drive Human Pre-Leukemic Hematopoietic Stem Cell Expansion And Promote Leukemic Aggressiveness 3.33
Transcriptome landscape of human primary monocytes response upon different ligand glucocorticoids 3.25
CHCHD2 gene KO effect in iPSC drived motor neurons 3.21
Generation of Brain Region-specific Organoids using a Miniaturized Spinning Bioreactor and Modelling ZIKV Exposure 3.19
Transcriptome of human ILC2s; primary vs IL-1b-primed 3.17
Transcriptome Profiling Reveals the key genes and pathways involved in polycystic ovary syndrome [RNA-seq] 3.0
Identification of epigenetic interactions between miRNA and DNA methylation associated with polycystic ovarian syndrome 3.0
Anaylsis of the effect of down-regulation of the EWS-FLI1 fusion protein in Ewing Sarcoma cells by RNA-seq. 3.0
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 2.98
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 2.93
Induction of Cardiomyocyte Proliferation [pz-822_human] 2.93
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration 2.93
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [inhibitor MRT199665] 2.91
Analysis of MGE Transcriptomes with or without Ctnnb1 knockout in human through RNA Sequencing 2.89
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells 2.86
EZHIP constrains Polycomb Repressive Complex 2 activity in germ cells (RNA-Seq) 2.86
Identification of renal resident macrophages across species [C1] 2.85
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 2.85
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 2.85
Musashi-2 attenuates AHR signalling to expand human haematopoietic stem cells 2.81
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 2.79
Generation of induced keratinocyte stem cells from human urine cells by defined transcription factors 2.77
Alternative splicing regulated by QKI and RBFOX1 promotes the mesenchymal cell state in breast cancer 2.76
RNA-sequencing in immortalized human mammary epithelial cells 2.76
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 2.74
Epigenome-wide analysis of DNA methylation in lung tissue shows concordance with blood studies and identifies tobacco smoke-inducible enhancers 2.74
Peripheral whole blood mRNAs and lncRNAs expression analysis in eosinophilic asthmatics 2.65
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. 2.56
Metastasis in triple-negative breast cancer 2.56
An optimization system for isolating and sequencing of single human colon cancer cells 2.56
Transcriptome profiling identified a 3-lncRNA regulatory network in transthyretin against glucose induced hRECs dysfunction 2.54
PER2 synchronizes mitotic expansion and decidual transformation of human endometrial stromal cells 2.45
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 2.43
Single-cell transcriptome of human epithelial cells reveals novel insights into early innate immune responses to influenza virus and viral antagonism 2.42
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_KD] 2.41
JunB control of keratinocyte-mediated inflammation [RNA-seq] 2.4
RNA-Seq and ChIP-Seq reveals SQSTM1/p62 as a key mediator of JunB suppression of NF-kB-dependent inflammation 2.4
RNA-Seq Samples of siTFE3 in 8988T PDA Cell Line to Investigate Transcriptional Control of the Autophagy-Lysosome System 2.39
MicroRNA-28 replacement for non-Hodgkin lymphoma therapy 2.35
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL [RNA-seq] 2.35
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL 2.35
The NFkB subunit RELA is a master transcriptional regulator of the committed epithelial-mesenchymal transition in airway epithelial cells 2.32
IL-10 dysregulation in acute mountain sickness revealed by transcriptome analysis 2.3
Multidimensional Assessment of the Host Response in Mechanically Ventilated Patients with Suspected Pneumonia 2.26
RNA-seq of exosomes identifies lncRNA profiles that distinguish early-stage esophageal squamous cell carcinoma (ESCC) from non-malignant esophagitis 2.25
Regulation of stem cell property and drug resistance of cancer cells by targeting transcriptional machinery via inhibition of neddylation 2.24
Distinct changes in transcriptional profiles and epigenetic patterns mediated by EZH2 inhibitors in sensitive and insensitive prostate cancer cells 2.23
EZH2 inhibitor-mediated transcriptional profiling in prostate cancer cells [RNA-seq] 2.23
Expression data for hiPSC-derived RPE treated with 10mM Nicotinamide or vehicle 2.2
The contribution of Alu exons to the human proteome 2.2
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [RNA-Seq III] 2.17
Gene expression analysis of human adenomas. 2.07
RNA-seq of H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 2.06
H9-hESC derived human neural stem cells with combinations of mutant IDH1-R132H overexpression, P53 shRNA knockdown and/or ATRX shRNA knockdown 2.06
Role of SUMOylation in differential ERα transcriptional repression by SERMs and pure antiestrogens in breast cancer cells 2.04
Defective structural RNA processing in relapsing-remitting multiple sclerosis 1.98
Genomic deletion of malic enzyme 2 confers collateral lethality in pancreas cancer 1.94
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 1.92
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 1.88
RNA-seq study reveals unique transcriptome expression in systemic lupus erythematosus patients with distinct autoantibody profile 1.86
Studying the selectivity of a targeted small molecule degrading a hypoxia-associated non-coding RNA 1.85
Sex differences in transcriptomic profiles in aged kidney cells of renin lineage 1.83
Transcriptomic profiling of human peripheral blood-derived mast cells 1.81
Genome-wide analyses of chromatin state in human mast cells reveal molecular drivers and mediators of allergic and inflammatory diseases 1.81
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq AML development) 1.78
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes (RNA-Seq) 1.77
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes 1.77
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 1.77
Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants 1.69
Group A Streptococcus M1T1 Intracellular Infection of Primary Tonsil Epithelial Cells Dampens Levels of Secreted IL-8 Through the Action of SpyCEP 1.66
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 1.61
EWS-Fli and LNC regulated genes in comparison to GFP samples 1.55
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. [RNA-Seq] 1.51
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. 1.51
RNA-Seq analysis of proliferating 4N and 2N RPE1 cells derived from single cell clones following inhibition of Aurora B to induce polyploidization [tpo10] 1.44
RNA-seq analysis upon ARID1B overexpression 1.43
The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4+ T-cells 1.41
Transcriptomic profile of intestinal epithelial cells obtained from ileal endoscopic biopsies from newly-diagnosed, pediatric Crohn's disease patients and healthy controls. 1.39
RNA expression profiles from HUVECs overexpressing adenovirally delivered HIF1a and HIF2a proteins 1.37
Functional Comparison of the HGF/Met and MSP/Ron Systems in a Pancreatic Cancer Model 1.33
Integrative analysis of RNA, translation and protein levels reveals distinct regulatory variation across humans 1.31
Human lymph nodes maintain a unique subset of resident memory T cells with high functional potential important for protective immunity and immunotherapies 1.27
EPCR Expression Defines the Most Primitive Subset of Human HSPC and Is Required for Their In Vivo Activity 1.24
iPSC-Derived Cholangiocytes 1.22
Sodium butyrate ameliorates aSyn-induced transcription deregulation and DNA damage 1.19
Interphase condensins regulate ligand-depedent enhancer activation 1.18
Interphase condensins regulate ligand-depedent enhancer activation (GRO-seq) 1.18
KSDM1b Role in Ewing Sarcoma 1.16
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-PBS / R-2HG treatment 1.16
JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias 1.15
Comparative gene expression profiling of MHH-CALL4 cells subject to pharmacological JAK2 inhibitor treatment (ruxolitinib or CHZ868) or shRNA-mediated JAK2 depletion in vitro 1.15
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses 1.11
Tpl-2 and MEK small molecule inhibitors 1.09
Tpl-2 small molecule project 1.09
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease 0.98
RNA-seq analysis of YFV-17D specific and total naive CD8 T cells in humans 0.97
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [Primary RNA-Seq] 0.95
Deep sequencing of transcript levels of human embryonic stem cell derived mesothelium (epithelial and mesenchymal forms) and mesothelium from neonatal mouse E15.5 of the heart, lung, liver and gut and ChIP-seq data of the mesenchymal form of mesothelium 0.88
RNA sequencing of CACO-2 cells incubated with Bifidobacteria breve grown on human milk oligosaccharides. 0.87
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 0.84
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.82
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation 0.82
mRNA-Seq profiling SIX2+ and Foxd1+ cells in mouse embryonic and SIX2+ and SIX2-/MEIS1+ cells human fetal kidney 0.77
Nucleoporin-mediated regulation of cell identity genes 0.76
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 0.7
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 0.65
RNA-Seq of cKIT+ sorted cells from 53-137 day old fetal testes and ovaries and RNA-Seq of TRA-1-81+ H1 and UCLA1 hESCs. 0.65
cKIT+ sorted cells from 57-137 day old fetal testes and ovaries 0.65
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 0.58
The role of the Calcium-Sensing receptor in colorectal cancer 0.56
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression 0.53
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression [RNA-Seq] 0.53
Human Tfh cell RNA bulk sequencing 0.48
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 0.46
CD74 role in transcription regulation [RNA-seq] 0.44
CD74 role in transcription regulation 0.44
Transcriptome-wide identification of transient RNA G-quadruplexes in human cells 0.43
Effects of plasticizers (bisphenol A, bisphenol AF) and an herbicide in MCF7 human breast cancer cells 0.43
hNSCs siRNA NOVA2 0.42
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 0.42
A cell-permeable stapled peptide inhibitor of the estrogen receptor/coactivator interaction 0.42
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity 0.4
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 0.36
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 0.34
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  0.34
Transcriptomic profile of T cell acute lymphoblastic leukemia (T-ALL) cell from patients in CHCQMU 0.33
RNA expression profiles comparing primary and omental ovarian carcinoma samples 0.32
A code of mono-phosphorylation modulates the function of RB. 0.3
Gene expression profiles of isogenic single-cell derived clones of BRAF-mutated SK-MEL-5 melanoma cell lines 0.28
RNA-seq analysis in Cornea epithelial cells (CECs), skin epithelial cells (SECs), LSCs after knocking down PAX6 (3-D shPAX6 LSCs) and SESCs transduced with PAX6(3-D PAX6+ SESCs) upon 3-D differentiation 0.24
The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells 0.24
Gene expression signatures of innate lymphoid cells from human blood 0.23
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 0.23
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 0.23
Comparing oestrogen-responsive genes in endometrial and breast cancer cell lines 0.22
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 0.17
Primate-specific gene TMEM14B promotes cortical expansion and folding 0.16
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 0.15
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 0.08
RNA sequencing of hiPSC derived neural crest populations from Familial Dysautonomia patients 0.07
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.04
Longitudinal transcriptome profiling of post-treatment Lyme disease syndrome 0.02


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation